Fentanyl Citrate
| Grade |
Pharmaceutical |
| Pharmacopoeia |
USP |
| CAS No. |
990-73-8 |
| Product Name |
Fentanyl Citrate |
| Chemical Name |
N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate |
| Function |
Active Pharmaceutical Ingredients (APIs) |
| Industrial Application |
Pharmaceutical |
| Category |
Non-opioid pain management |
General Description
Fentanyl citrate is a synthetic opioid used for treatment of moderate to severe pain with a short term effect and used in multiple doses daily.
Unlike morphine, it does not affect histamine release.
Fentanyl transdermal onset is 6-8 hours and the effect lasts for 72 hours.
Physical Characteristics
| Molecular formula |
C₂₈H₃₆N₂O₈ |
| Molecular weight |
528.6 |
| Appearance |
White or almost white powder |
| Solubility |
Soluble in water, freely soluble in methanol, sparingly soluble in ethanol (96%), very slightly soluble in methylene chloride |
| Melting point |
About 152 °C, with decomposition |
| Water |
Maximum 0.5% |
| Residue on ignition |
Maximum 0.5% |
| Purity |
Minimum 99.6% |
| Assay |
99.0% to 101.0% (dried substance) |
| Storage |
Protected from light |
| Stability |
Stable at least 2 years at room temperature |
